Balimbingan, Lita .

HRN: 16-72-89  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/19/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
03/19/2025
03/26/2025
IVT
500 Gm
Q 8h
T/c Partial Mechanical Bowel Obstruction
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Intra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: